There's that figure again.....1,5 million. We know there are more. This is very very encouraging. Does anyone know about phase 3? This is a non dopaminergic trial and it has made it past phase 2 .....yowsah!

"This is great news for the 1.5 million Americans living with Parkinson's disease," adds Dr. During, who is the co-inventor, with Dr. Kaplitt, of the gene therapy procedure. "Since this is also the first gene therapy study for a neurological disease to achieve success in a rigorous randomized, double-blind design compared with a sham group, this is also a crucial step forward toward finally bringing gene therapy into clinical practice for patients with debilitating brain disorders."

Now we also need to pass S425 to get that registry.